Recovered $24.9 million in whistleblower settlement over illegal kickbacks to long-term care pharmacies
Plaintiff(s):
U.S. ex rel. Kurnik
Case type / claims:
Whistleblower action under the False Claims Act alleging Amgen paid kickbacks to long-term care pharmacies to induce switching elderly patients to its anemia drug, Aranesp. The alleged kickbacks included market-share and volume-based rebates, grants, honoraria, speaker fees, consulting services, dinners, travel, and purchases of unnecessary data.
Defendant(s):
Amgen, Inc., et al.
Jurisdiction:
U.S. District Court for the District of South Carolina
Year:
2013
Outcome:
- Settled for $24.9 million to resolve federal and state False Claims Act allegations.
